Broncus Holding Corp 02216
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 0.61
- Day Range
- HKD 0.56–0.60
- 52-Week Range
- HKD 0.46–1.76
- Bid/Ask
- HKD 0.58 / HKD 0.60
- Market Cap
- HKD 283.43 Mil
- Volume/Avg
- 1.0 Mil / 288,960
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.53
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Broncus Holding Corp is a medical device company focused on the development of interventional pulmonology products. It is engaged in the field of interventional pulmonology, providing innovative lung solutions in China and globally. The integrated interventional pulmonology platform addresses the pain points of the existing diagnosis and treatment paradigms and significant unmet medical needs for lung diseases by improving the diagnosis and treatment effects of lung cancer and COPD.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 308
- Website
- https://www.broncus.com
Comparables
Valuation
|
Metric
|
02216
|
02172
|
01302
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 24.82 | 13.51 |
Price/Book Value | 0.21 | 3.06 | 2.33 |
Price/Sales | 3.53 | 7.50 | 5.90 |
Price/Cash Flow | — | 21.79 | 16.81 |
Price/Earnings
02216
02172
01302
Financial Strength
|
Metric
|
02216
|
02172
|
01302
|
|---|---|---|---|
Quick Ratio | 28.75 | 4.17 | 1.90 |
Current Ratio | 29.58 | 5.35 | 3.05 |
Interest Coverage | −351.70 | 43.05 | — |
Quick Ratio
02216
02172
01302
Profitability
|
Metric
|
02216
|
02172
|
01302
|
|---|---|---|---|
Return on Assets (Normalized) | −12.95% | 8.50% | 3.76% |
Return on Equity (Normalized) | −14.48% | 10.32% | 4.69% |
Return on Invested Capital (Normalized) | −16.33% | 9.14% | 4.69% |
Return on Assets
02216
02172
01302
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Rxcpvfpnn | Rfqlp | $182.6 Bil | |
SYK
| Stryker Corp | Zqprjcrr | Qywtv | $125.9 Bil | |
MDT
| Medtronic PLC | Jdhkhbxk | Jhnrk | $108.3 Bil | |
BSX
| Boston Scientific Corp | Ggkdxpkw | Nxgdfv | $106.9 Bil | |
EW
| Edwards Lifesciences Corp | Wwfsyxltdw | Frvkwl | $52.3 Bil | |
DXCM
| DexCom Inc | Mrqjshcfx | Fhbgf | $50.3 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mqbvxmff | Mtwck | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Qjmvgvwml | Ldzln | $24.3 Bil | |
ALGN
| Align Technology Inc | Ffnqsqcn | Gsqfvt | $21.1 Bil | |
PODD
| Insulet Corp | Swnyjghlft | Tkmkjm | $12.4 Bil |